Chromadex Corp Share Price OTC Bulletin Board
Equities
CDXC
US1710771007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-01 | ChromaDex Joins Russell 2000 Index | MT |
07-01 | ChromaDex Corporation(NasdaqCM:CDXC) added to Russell Small Cap Completeness Index | CI |
Sales 2024 * | 96.57M 7.54B | Sales 2025 * | 114M 8.9B | Capitalization | 190M 14.84B |
---|---|---|---|---|---|
Net income 2024 * | -1M -78.08M | Net income 2025 * | 4M 312M | EV / Sales 2024 * | 1.97 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
-314
x | P/E ratio 2025 * |
40.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 64.21% |
Latest transcript on Chromadex Corp
Managers | Title | Age | Since |
---|---|---|---|
Robert Fried
CEO | Chief Executive Officer | 64 | 08/07/15 |
Frank Jaksch
FOU | Founder | 55 | 31/12/98 |
Brianna Gerber
DFI | Director of Finance/CFO | 44 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 26/03/17 |
Hamed Shahbazi
BRD | Director/Board Member | 49 | 08/08/22 |
Frank Jaksch
FOU | Founder | 55 | 31/12/98 |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- CDXC Stock
- CDXC Stock